# LLM Agent Swarm for Hypothesis-Driven Drug Discovery

arXiv: https://arxiv.org/abs/2504.17967 · HTML: https://mlsanity.com/paper/2504.17967/

## Key facts

- Cited by 8 papers in the map (data through 14 Oct 2026).
- Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use.
- Builds on 5 of its 23 references that are in the map.
- First posted on arXiv 24 Apr 2025.

## Placed in

- LLM agents and tool use / [Medical and scientific domain agents](https://mlsanity.com/agents/medical-and-scientific-domain-agents/)

## Builds on (most cited first, 5 of 5)

- [GPT-4 Technical Report](https://mlsanity.com/paper/2303.08774/) (2023)
- [On the Opportunities and Risks of Foundation Models](https://mlsanity.com/paper/2108.07258/) (2021)
- [ChemBERTa: Large-Scale Self-Supervised Pretraining for Molecular Property Prediction](https://mlsanity.com/paper/2010.09885/) (2020)
- [Learning to Plan Chemical Syntheses](https://mlsanity.com/paper/1708.04202/) (2017)
- [TxGemma: Efficient and Agentic LLMs for Therapeutics](https://mlsanity.com/paper/2504.06196/) (2025)

## Built on by (most cited first, 8 of 8)

- [Autonomous Research Agents: A Survey of AI Scientists and the Verification Gap](https://mlsanity.com/paper/2608.05179/) (2026)
- [Mozi: Governed Autonomy for Drug Discovery LLM Agents](https://mlsanity.com/paper/2603.03655/) (2026)
- [SwarmWorld: Stigmergic technological evolution in societies of language-model agents](https://mlsanity.com/paper/2608.26081/) (2026)
- [DrugMCTS: a drug repurposing framework combining multi-agent, RAG and Monte Carlo Tree Search](https://mlsanity.com/paper/2507.07426/) (2025)
- [Agentic Inequality](https://mlsanity.com/paper/2510.16853/) (2025)
- [Uncovering Bottlenecks and Optimizing Scientific Lab Workflows with Cycle Time Reduction Agents](https://mlsanity.com/paper/2505.21534/) (2025)
- [Agentic AI in Healthcare & Medicine: A Seven-Dimensional Taxonomy for Empirical Evaluation of LLM-based Agents](https://mlsanity.com/paper/2602.04813/) (2026)
- [SciCustom: A Framework for Custom Evaluation of Scientific Capabilities in Large Language Models](https://mlsanity.com/paper/2605.19357/) (2026)

## Abstract (arXiv)

Drug discovery remains a formidable challenge: more than 90 percent of candidate molecules fail in clinical evaluation, and development costs often exceed one billion dollars per approved therapy. Disparate data streams, from genomics and transcriptomics to chemical libraries and clinical records, hinder coherent mechanistic insight and slow progress. Meanwhile, large language models excel at reasoning and tool integration but lack the modular specialization and iterative memory required for regulated, hypothesis-driven workflows. We introduce PharmaSwarm, a unified multi-agent framework that orchestrates specialized LLM "agents" to propose, validate, and refine hypotheses for novel drug targets and lead compounds. Each agent accesses dedicated functionality--automated genomic and expression analysis; a curated biomedical knowledge graph; pathway enrichment and network simulation; interpretable binding affinity prediction--while a central Evaluator LLM continuously ranks proposals by biological plausibility, novelty, in silico efficacy, and safety. A shared memory layer captures validated insights and fine-tunes underlying submodels over time, yielding a self-improving system. Deployable on low-code platforms or Kubernetes-based microservices, PharmaSwarm supports literature-driven discovery, omics-guided target identification, and market-informed repurposing. We also describe a rigorous four-tier validation pipeline spanning retrospective benchmarking, independent computational assays, experimental testing, and expert user studies to ensure transparency, reproducibility, and real-world impact. By acting as an AI copilot, PharmaSwarm can accelerate translational research and deliver high-confidence hypotheses more efficiently than traditional pipelines.